Hot Features
Premium
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Period:
Draw Mode:
| Volume | 4,385 |
|
|||||
| News | - |
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Carmell Corporation | CTCXW | NASDAQ | Equity Warrant |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.0136 | 59.39% | 0.0365 | 17:54:02 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.0299 | 0.0299 | 0.0415 | 0.0365 | 0.0229 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume |
|---|---|---|---|---|
| 20 | 4,385 | 0.0346142 | 152 | - |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 15:00:00 | 315 | 0.0365 | USD |
Carmell Corporation Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 528.58k | 23.08M | - | 0 | -16.12M | -0.70 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
News Carmell
| Date | Time | Source | Heading |
|---|---|---|---|
| 2/13/2025 | 16:00 | Edgar (US Regulatory) | Form 424B3 - Prospectus [Rule 424(b)(3)] |
| 2/12/2025 | 23:15 | Edgar (US Regulatory) | Form EFFECT - Notice of Effectiveness |
| 2/10/2025 | 16:23 | Edgar (US Regulatory) | Form DEF 14A - Other definitive proxy statements |
| 2/10/2025 | 16:01 | Edgar (US Regulatory) | Form DEF 14A - Other definitive proxy statements |
| 2/03/2025 | 16:00 | Edgar (US Regulatory) | Form S-3 - Registration statement under Securities Act of.. |
| 1/31/2025 | 16:00 | Edgar (US Regulatory) | Form PRE 14A - Other preliminary proxy statements |
| 1/27/2025 | 06:58 | Edgar (US Regulatory) | Form 424B3 - Prospectus [Rule 424(b)(3)] |
| 1/24/2025 | 16:00 | Edgar (US Regulatory) | Form 8-K - Current report |
| 1/16/2025 | 09:31 | Edgar (US Regulatory) | Form 424B3 - Prospectus [Rule 424(b)(3)] |
| 1/16/2025 | 07:00 | Edgar (US Regulatory) | Form 8-K - Current report |
| 1/03/2025 | 16:28 | Edgar (US Regulatory) | Form 424B3 - Prospectus [Rule 424(b)(3)] |
| 1/03/2025 | 16:21 | Edgar (US Regulatory) | Form 8-K - Current report |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
CTCXW Historical
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 1 Month | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 3 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 6 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 1 Year | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 3 Years | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 5 Years | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| Carmell Corporation (CTCX) is a bio-aesthetics company that utilizes the Carmell SecretomeTM to support skin and hair health. The Carmell SecretomeTM consists of a potent cocktail of growth factors and proteins extracted from allogeneic human platelets sourced from U.S. Food and Drug Administration-approved tissue banks. Over the past seven years, Carmell has extensively tested the technology underpinning the Carmell SecretomeTM. In addition, Carmell has developed a novel microemulsion formulation that enables the delivery of lipophilic and hydrophilic ingredients without relying on the Foul FourteenTM, which are 14 potentially harmful excipients that are commonly used by other companies to impart texture, stability, and other desirable physicochemical attributes to cosmetic products. Additionally, Carmell's microemulsion formulations do not utilize mineral or vegetable oils across its entire product line and are designed to be non-comedogenic. |
NASDAQ:CTCXW -
What is the current Carmell Corporation share price?
The current share price of Carmell Corporation is US$ 0.0365
How many Carmell Corporation shares are in issue?
Carmell Corporation has 23,082,000 shares in issue
What is the market cap of Carmell Corporation?
The market capitalisation of Carmell Corporation is USD 528.58k
What is the 1 year trading range for Carmell Corporation share price?
Carmell Corporation has traded in the range of US$ 0.00 to US$ 0.00 during the past year
What is the PE ratio of Carmell Corporation?
The price to earnings ratio of Carmell Corporation is -0.34
What is the reporting currency for Carmell Corporation?
Carmell Corporation reports financial results in USD
What is the latest annual profit for Carmell Corporation?
The latest annual profit of Carmell Corporation is USD -16.12M
What is the registered address of Carmell Corporation?
The registered address for Carmell Corporation is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Carmell Corporation website address?
The website address for Carmell Corporation is www.carmellrx.com
Which industry sector does Carmell Corporation operate in?
Carmell Corporation operates in the SURGICAL,MED INSTR,APPARATUS sector
